Association between total hip replacement characteristics and 3-year prosthetic survivorship: A population-based study

JAMA Surgery

Volumn 150, Issue 10, 2015, Pages 979-988

  Colas, Sandrine ^a   Collin, Cédric ^a   Piriou, Philippe ^b   Zureik, Mahmoud ^a  

^a Department of Epidemiology of Health Products   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEMENTED PROSTHESIS; CEMENTLESS PROSTHESIS; CERAMIC ON CERAMIC JOINT PROSTHESIS; CERAMIC ON POLYETHYLENE PROSTHESIS; CONTROLLED STUDY; COXITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL ON METAL JOINT PROSTHESIS; METAL ON POLYETHYLENE JOINT PROSTHESIS; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS FIXATION; SENSITIVITY ANALYSIS; TOTAL HIP PROSTHESIS; WEIGHT BEARING; HIP ARTHROPLASTY; HIP PROSTHESIS; MIDDLE AGED; PROSTHESIS; PROSTHESIS FAILURE; REOPERATION; TIME;

BONE CEMENT;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; FEMALE; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REOPERATION; TIME FACTORS;

EID: 84944809957     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.1325     Document Type: Article

References (60)

1. Clement ND, Breusch SJ, Biant LC. Lower limb joint replacement in rheumatoid arthritis. J Orthop Surg Res. 2012;7:27.
2. Bohensky M, Ackerman I, de Steiger R, Gorelik A, Brand C. Lifetime risk of total hip replacement surgery and temporal trends in utilization: a population-based analysis. Arthritis Care Res (Hoboken). 2014;66(8):1213-1219.
3. Nemes S, Gordon M, Rogmark C, Rolfson O. Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop. 2014;85(3):238-243.
4. Villanueva-Martinez M, Hernandez-Barrera V, Chana-Rodríguez F, et al. Trends in incidence and outcomes of revision total hip arthroplasty in Spain: a population based study. BMC Musculoskelet Disord. 2012;13:37.
5. Australian Orthopaedic Association-National Joint Replacement Registry. Australian Orthopaedic Association-National Joint Replacement Registry: annual report 2014. https://aoanjrr.dmac.adelaide.edu.au/documents/10180/172286/Annual%20Report%202014. Accessed October 15, 2014.
6. Canadian Institute for Health Information. Hip and knee replacements in Canada: Canadian Joint Replacement Registry 2014 Annual Report. https://secure.cihi.ca/free-products/CJRR%202014%20Annual%20Report-EN-web.pdf. Accessed October 15, 2014.
7. Centre of Excellence of Joint Replacements. Nasjonalt Register for Leddproteser: report June 2010. http://nrlweb.ihelse.net/eng/Report-2010.pdf. Accessed October 15, 2014.
8. National Joint Registry. NJR 11th annual report 2014. http://www.njrcentre.org.uk/njrcentre/Portals/0/Documents/England/Reports/11th-annual-report/NJR%2011th%20Annual%20Report%202014.pdf. Accessed October 15, 2014.
9. Netherlands Orthopaedic Association. Insight into quality of orthopaedic care in the Netherlands - annual report of the Dutch Arthroplasty Register (Landelijke Registratie Orthopedische Implantaten). 2012. http://www.lroi.nl/uploads/dd/hs/ddhsXrrhkkSoA-vpBMBMKA/LROI-report-Executive-summary-Insight-into-quality-of-orthopaedic-care-in-the-Netherlands.pdf. Accessed October 15, 2014.
10. New Zealand Joint Registry. The New Zealand Joint Registry-14-year report-January 1999 to December 2012. http://www.nzoa.org.nz/system/files/NJR%2014%20Year%20Report.pdf. Accessed October 15, 2014.
11. Swedish Hip Arthroplasty Register. Swedish Hip Arthroplasty Register annual report 2012. http://www.shpr.se/en/Publications/DocumentsReports.aspx. Accessed October 15, 2014.
12. Labek G, Thaler M, Janda W, Agreiter M, Stöckl B. Revision rates after total joint replacement: cumulative results from worldwide joint register datasets. J Bone Joint Surg Br. 2011;93(3):293-297.
13. Corbett KL, Losina E, Nti AA, Prokopetz JJZ, Katz JN. Population-based rates of revision of primary total hip arthroplasty: a systematic review. PLoS One. 2010;5(10):e13520.
14. Philpott A, Weston-Simons JS, Grammatopoulos G, et al. Predictive outcomes of revision total hip replacement-a consecutive series of 1176 patients with a minimum 10-year follow-up. Maturitas. 2014;77(2):185-190.
15. Lui DF, Bandorf N, Riordan P, Jaweesh O, Duru B, Bennett D. Preoperative comorbidity and modes of failure in revision hip arthroplasty: a single-surgeon series in a tertiary referral centre. Eur J Orthop Surg Traumatol. 2013;23(3):329-333.
16. Wolf BR, Lu X, Li Y, Callaghan JJ, Cram P. Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am. 2012;94(14):e103.
17. Hailer NP, Garellick G, Kärrholm J. Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop. 2010;81(1):34-41.
18. Morshed S, Bozic KJ, Ries MD, Malchau H, Colford JM Jr Comparison of cemented and uncemented fixation in total hip replacement: a meta-analysis. Acta Orthop. 2007;78(3):315-326.
19. Sibanda N, Copley LP, Lewsey JD, et al.; Steering Committee of the National Joint Registry (NJR) for England and Wales. Revision rates after primary hip and knee replacement in England between 2003 and 2006. PLoS Med. 2008;5(9):e179.
20. Mäkelä KT, Matilainen M, Pulkkinen P, et al. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ. 2014;348:f7592.
21. Troelsen A, Malchau E, Sillesen N, Malchau H. A review of current fixation use and registry outcomes in total hip arthroplasty: the uncemented paradox. Clin Orthop Relat Res. 2013;471(7):2052-2059.
22. Corten K, Bourne RB, Charron KD, Au K, Rorabeck CH. What works best, a cemented or cementless primary total hip arthroplasty? minimum 17-year followup of a randomized controlled trial. Clin Orthop Relat Res. 2011;469(1): 209-217.
23. Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop. 2008;79(3): 335-341.
24. Wang J, Zhu C, Cheng T, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One. 2013;8(12):e82745.
25. Topolovec M, Milošev I. A comparative study of four bearing couples of the same acetabular and femoral component: a mean follow-up of 11.5 years. J Arthroplasty. 2014;29(1):176-180.
26. Kim Y-H, Park J-W, Kulkarni SS, Kim Y-H. A randomised prospective evaluation of ceramic-on-ceramic and ceramic-on-highly cross-linked polyethylene bearings in the same patients with primary cementless total hip arthroplasty. Int Orthop. 2013;37(11):2131-2137.
27. Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H. Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia. 2012;55(7):1953-1962.
28. Fagot J-P, Blotière P-O, Ricordeau P, Weill A, Alla F, Allemand H. Does insulin glargine increase the risk of cancer compared with other basal insulins? a French nationwide cohort study based on national administrative databases. Diabetes Care. 2013;36(2):294-301.
29. Romon I, Rey G, Mandereau-Bruno L, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes: the 2001-2006 ENTRED cohort. Diabet Med. 2014;31(8):946-953.
30. Bouillon K, Bertrand M, Maura G, Blotière P-O, Ricordeau P, Zureik M. Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study. Lancet Haematol. 2015;2: e150-159. http://dx.doi.org/10.1016/S2352-3026(15)00027-7
31. Racine A, Cuerq A, Bijon A, et al. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study. Am J Gastroenterol. 2014;109(4): 563-569.
32. Tiv M, Viel J-F, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One. 2012;7(3):e32412.
33. Tuppin P, Cuerq A, de Peretti C, et al. Two-year outcome of patients after a first hospitalization for heart failure: a national observational study. Arch Cardiovasc Dis. 2014;107(3):158-168.
34. Martin-Latry K, Bégaud B. Pharmacoepidemio-logical research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf. 2010;19(3):256-265.
35. Bozic KJ, Lau E, Ong K, et al. Risk factors for early revision after primary total hip arthroplasty in Medicare patients. Clin Orthop Relat Res. 2014;472 (2):449-454.
36. Dy CJ, Bozic KJ, Pan TJ, Wright TM, Padgett DE, Lyman S. Risk factors for early revision after total hip arthroplasty. Arthritis Care Res (Hoboken). 2014; 66(6):907-915.
37. Prokopetz JJ, Losina E, Bliss RL, Wright J, Baron JA, Katz JN. Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord. 2012;13:251.
38. Ravi B, Jenkinson R, Austin PC, et al. Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study. BMJ. 2014;348:g3284.
39. Judge A, Chard J, Learmonth I, Dieppe P. The effects of surgical volumes and training centre status on outcomes following total joint replacement: analysis of the Hospital Episode Statistics for England. J Public Health (Oxf). 2006; 28(2):116-124.
40. Rey G, Jougla E, Fouillet A, Hémon D. Ecological association between a deprivation index and mortality in France over the period 1997-2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. 2009;9:33.
41. Lie SA, Engesaeter LB, Havelin LI, Gjessing HK, Vollset SE. Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand. 2000;71(1):19-27.
42. Gillam MH, Salter A, Ryan P, Graves SE. Different competing risks models applied to data from the Australian Orthopaedic Association National Joint Replacement Registry. Acta Orthop. 2011;82(5):513-520.
43. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
44. Ranstam J. Problems in orthopedic research: dependent observations. Acta Orthop Scand. 2002; 73(4):447-450.
45. Stea S, Comfort T, Sedrakyan A, et al. Multinational comprehensive evaluation of the fixation method used in hip replacement: interaction with age in context. J Bone Joint Surg Am. 2014;96(SUPPL. 1):42-51.
46. Moritz N, Alm JJ, Lankinen P, Mäkinen TJ, Mattila K, Aro HT. Quality of intertrochanteric cancellous bone as predictor of femoral stem RSA migration in cementless total hip arthroplasty. J Biomech. 2011;44(2):221-227.
47. Aro HT, Alm JJ, Moritz N, Mäkinen TJ, Lankinen P. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients. Acta Orthop. 2012;83(2):107-114.
48. Hartikainen S, Lönnroos E. Systematic review: use of sedatives and hypnotics, antidepressants and benzodiazepines in older people significantly increases their risk of falls. Evid Based Med. 2010;15 (2):59.
49. Wylde V, Blom AW. The failure of survivorship. J Bone Joint Surg Br. 2011;93(5):569-570.
50. Robertsson O, Ranstam J. No bias of ignored bilaterality when analysing the revision risk of knee prostheses: analysis of a population based sample of 44,590 patients with 55,298 knee prostheses from the national Swedish Knee Arthroplasty Register. BMC Musculoskelet Disord. 2003;4:1.
51. Amlie E, Havelin LI, Furnes O, et al. Worse patient-reported outcome after lateral approach than after anterior and posterolateral approach in primary hip arthroplasty: a cross-sectional questionnaire study of 1,476 patients 1-3 years after surgery. Acta Orthop. 2014;85(5):463-469.
52. Choy GGH, Roe JA, Whitehouse SL, Cashman KS, Crawford RW. Exeter short stems compared with standard length Exeter stems: experience from the Australian Orthopaedic Association National Joint Replacement Registry. J Arthroplasty. 2013;28(1):103-109.e1.
53. Kim Y-H, Park J-W, Kim J-S. Behaviour of the ultra-short anatomic cementless femoral stem in young and elderly patients. Int Orthop. 2013;37(12): 2323-2330.
54. van Oldenrijk J, Molleman J, Klaver M, Poolman RW, Haverkamp D. Revision rate after short-stem total hip arthroplasty: a systematic review of 49 studies. Acta Orthop. 2014;85(3):250-258.
55. Wittenberg RH, Steffen R, Windhagen H, Bücking P, Wilcke A. Five-year results of a cementless short-hip-stem prosthesis. Orthop Rev (Pavia). 2013;5(1):e4.
56. Jameson SS, Baker PN, Mason J, et al. The design of the acetabular component and size of the femoral head influence the risk of revision following 34 721 single-brand cemented hip replacements: a retrospective cohort study of medium-term data from a National Joint Registry. J Bone Joint Surg Br. 2012;94(12):1611-1617.
57. Mäkelä K. Primary total hip arthroplasty for primary osteoarthritis in Finland: a national register based analysis. 2010. https://helda.helsinki.fi/handle/10138/22460. Accessed October 15, 2014.
58. Cummins JS, Tomek IM, Kantor SR, Furnes O, Engesaeter LB, Finlayson SRG Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am. 2009;91(3):634-641.
59. Merollini KMD, Crawford RW, Whitehouse SL, Graves N. Surgical site infection prevention following total hip arthroplasty in Australia: a cost-effectiveness analysis. Am J Infect Control. 2013;41(9):803-809.
60. Gutowski CJ, Zmistowski BM, Clyde CT, Parvizi J. The economics of using prophylactic antibiotic-loaded bone cement in total knee replacement. Bone Joint J. 2014;96-B(1):65-69.